Robert Nelsen, 10% Owner at Neumora Therapeutics, Inc. (NMRA), bought 83,008 shares at $11.73 ($1.0M) on 2023-09-26, disclosed to the SEC on 2023-09-27.
Open-market purchase of $1.0M NMRA by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.73 | 34,000 | $399K | 39.8% |
| 2 | $12.31 | 24,504 | $302K | 30.1% |
| 3 | $12.31 | 24,504 | $302K | 30.1% |
| Total | $12.07 avg | 83,008 | $1.0M | 100% |
| Filing → |
| SANA | BUY | 2024-02-12 | $8.0M | — | Filing → |
| NMRA | BUY | 2023-09-29 | $2.1M | — | Filing → |
| NMRA | BUY | 2023-09-25 | $1.8M | — | Filing → |